View Press Releases
-
High-Standard Fermented Raw Materials that Satisfy the Quality Attributes of Healthcare Products
BOC Sciences is able to provide clients with high-standard fermented raw materials that satisfy the quality attributes of finished healthcare products.
Oct 11, 2022
-
New Cotiviti Solution Enables Health Plans to Predict and Improve Medicare Advantage Star Ratings
Amid industry-wide ratings decline, Star Intelligence helps organizations track, predict, and model CMS Star Ratings
Oct 10, 2022
-
ChargePoint Technology collaborates with STERIS to deliver sterile solution success for Evonik
-
Watson-Marlow introduces KROHNE flowmeter to safeguard accuracy of fluid flow
Watson-Marlow Fluid Technology Solutions announces the company now offers the KROHNE FLEXMAG 4050 C ® electromagnetic flowmeter for biopharmaceutical customers. As a highly accurate and reliable flow measuring system that seamlessly integrates with other WMFTS products, it reinforces the company’s position as a provider of total-solution packages for customers utilising fluid path processes.
Oct 10, 2022
-
CTL Amedica gets FDA clearance for MONDRIAN™ ALIF Cage System with Supplementary Fixation Plate
CTL Amedica Corporation has received official 510k clearance from the U.S. FDA to market its MONDRIAN Anterior Lumbar Interbody Fusion (ALIF) Cage System with Supplementary Fixation Plate. It features CTL Amedica’s proprietary TiCro surface technology, which significantly increases endplate contact surface area and enhances interlocking properties.
Oct 10, 2022
-
BOC Sciences Rolled Out PEG GMP Manufacture Services for Broad Applications
BOC Sciences recently launched the PEG GMP manufacture service, a novel solution that aims at providing GMP-grade PEG products for a wide scope of applications.
Oct 9, 2022
-
BOC Sciences Reports Its Antibody Modification and Conjugation Technologies in Detail
The chief technician of BOC Sciences ADC development center recently reported some detailed information regarding its antibody modification and conjugation technologies, bringing the audience and customers a better understanding of how BOC Sciences has contributed to the ADC industry.
Oct 9, 2022
-
BOC Sciences Honored To Assist in the Antibody Research With High-Quality Chemicals
BOC Sciences' chemical products have been applied in a wide range of research projects and helped achieve groundbreaking breakthroughs.
Oct 9, 2022
-
BOC Sciences Declares the Availability of 10,000 Impurities, All in Stock!
BOC Sciences recently confirmed to its customers that over 10,000 impurities are now in stock, ready for immediate delivery.
Oct 9, 2022
-
AxisPharm's research in the field of bioanalysis and PK drive
AxisPharm bioanalytical chemistry department specializes in developing and validating robust bioanalytical methods for PK/TK sample analysis of small molecules, proteins, peptides, and metabolites using LCMS/MS (HPLC, UPLC, on-line SPE), HPLC/UV, and HPLC/FL.
Oct 9, 2022
-
MicrobioSeq Announces the Launch of the Phage Whole-Genome Sequencing Service
-
CD Genomics RNA-Solutions Platform Now Provides Whole Transcriptome Sequencing Service
-
CD Formulation Plays a Role in Developing Drug Delivery Systems
-
Alfa Chemistry: Expertise in Perovskite Quantum Dot Supply
-
Applications of Liposomal Drug Delivery System Technology
-
Mxene Materials Help Unlock Future Nanotechnologies
-
Genezen delivers next phase of cGMP lentiviral and retroviral vector production facility expansion
Genezen has completed another expansion at its viral vector process development and cGMP vector production facility in Fishers, Indiana (US).
Oct 6, 2022
-
Genedata Biologics Usage Expanded by Sanofi for Platformization of HT Multi-Specific Antibody Engineering
Global Biopharma leader drives digital innovation and AI-based biopharma R&D by expanding footprint of Genedata Biopharma Platform
Oct 5, 2022
-
Amphista Therapeutics partners with Domainex to advance portfolio of drug discovery projects targeting protein degradation
Amphista Therapeutics Ltd has selected Domainex Ltd as one of its trusted partners to provide integrated drug discovery services to support its research programmes. Domainex will provide expertise in protein production, assay biology and medicinal chemistry.
Oct 5, 2022
-
Quotient Sciences Expands UK Facilities to Support the Delivery of Translational Pharmaceutics® Programs
Company increases laboratory and clinical capacity to meet demand for fully integrated drug development capabilities
Oct 4, 2022